Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial
- Resource Type
- Article
- Source
- In
Journal of the American Academy of Dermatology June 2024 90(6):1232-1239 - Subject
- Language
- ISSN
- 0190-9622